Dasatinib: Tumour lysis syndrome: case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1320, 2010-01, pp. : 19-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Paclitaxel: Tumour lysis syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1129, 2006-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Rituximab: Acute tumour lysis syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1088, 2006-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Imatinib: Tumour lysis syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Methylprednisolone: Tumour lysis syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1266, 2009-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Sorafenib: Fatal tumour lysis syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1292, 2010-01 ,pp. : 34-34

Adis International

Access to resources Recommend Favorite